APA (7th ed.) Citation

Chul Hwan Bang, Hyun Ju Oh, Yeong Ho Kim, Jin-Hyung Jung, Ji Hyun Lee, Young Min Park, & Ju Hee Han. (2024). Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors. Medical Journals Sweden.

Chicago Style (17th ed.) Citation

Chul Hwan Bang, Hyun Ju Oh, Yeong Ho Kim, Jin-Hyung Jung, Ji Hyun Lee, Young Min Park, and Ju Hee Han. Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors. Medical Journals Sweden, 2024.

MLA (9th ed.) Citation

Chul Hwan Bang, et al. Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors. Medical Journals Sweden, 2024.